PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

Market Cap	9.70B
Revenue (ttm)	1.86B
Net Income (ttm)	193.35M
Shares Out	219.54M
EPS (ttm)	0.96
PE Ratio	46.07
Forward PE	40.54
Dividend	0.28 (0.62%)
Ex-Dividend Date	May 30, 2025

Volume	10,937,241
Average Volume	15,156,381
Open	43.27
Previous Close	45.36
Day's Range	43.27 - 45.65
52-Week Range	24.38 - 53.54
Beta	0.71
RSI	46.04
Earnings Date	Aug 8, 2025

About SHE:300725

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production. It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment based drug discovery, DNA encoded library technology, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and Full Time Equivalent (FTE). The company also provides small molecule drug substance CDMO se...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 2,455
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300725

Financial Performance

In 2024, SHE:300725's revenue was 1.69 billion, a decrease of -2.12% compared to the previous year's 1.73 billion. Earnings were 219.54 million, an increase of 11.24%.